References
- Lyngse FP, Kirkeby CT, Denwood M, Christiansen LE, Mølbak K, Møller CH, Skov RL, Krause TG, Rasmussen M, Sieber RN, et al. Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish Households. MedRxiv [Preprint]. 2022. doi:10.1101/2022.01.28.22270044.
- Kuodi P, Gorelik Y, Zayyad H, Wertheim O, Wiegler KB, Abu Jabal K, Dror AA, Nazzal S, Glikman D, Edelstein M. Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021. MedRxiv [Preprint]. 2022. doi:10.1101/2022.01.05.22268800.
- Zambrano LD, Newhams MM, Olson SM, Halasa NB, Price AM, Boom JA, Sahni LC, Kamidani S, Tarquinio KM, Maddux AB, et al. Overcoming COVID-19 investigators. Effectiveness of BNT162b2 (Pfizer-BioNtech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12–18 years — United States, July–December 2021. MMWR Morb Mortal Wkly Rep. 2022;71(2):52–2. doi:10.15585/mmwr.mm7102e1.
- Ameri M, Lewis H, Nguyen J. Immunogenicity and safety of inactivated Influenza Split-Virion vaccine administered via a transdermal micro needle system. J Vaccines Immunol. 2021;7:041–048.
- Rurik JG, Tombácz I, Yadegari A, Méndez Fernández PO, Shewale SV, Li L, Kimura T, Soliman OY, Papp TE, Tam YK, et al. CAR T cells produced in vivo to treat cardiac injury. Science. 2022;375(6576):91–96. doi:10.1126/science.abm0594.
- Kim C, Hovakimyan A, Zagorski K, Antonyan T, Petrushina I, Davtyan H, Chailyan G, Hasselmann J, Iba M, Adame A, et al. Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies. NPJ Vaccines. 2022;7(1):1. doi:10.1038/s41541-021-00424-2.